A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations

NCT01476189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Experimental paracetamol formulation
DRUG: Marketed paracetamol
DRUG: Higher dose marketed paracetamol

Sponsor

GlaxoSmithKline